Bruno Paiva is Director of the Flow Cytometry Platform and Director of the Monoclonal Gammopathies Research Laboratory, both at the centre for applied medical research (CIMA) University of Navarra, Pamplona, Spain, where he is also a research fellow of the Department of Haematology. He gained his Doctor of Pharmacy degree in in 2007 from the University of Coimbra, Portugal, and his PhD at the Medical School of the University of Salamanca, Spain.

Dr Paiva’s main area of expertise is the multidimensional flow cytometry analysis of haematological malignancies. His research focuses on immunogenomics to improve differential diagnosis, risk stratification, and monitoring of patients with monoclonal gammopathies and myeloid malignancies. Dr Paiva’s flow cytometry core is the referral laboratory for numerous Hospitals and has been the core of more than 30 national and international clinical trials in multiple myeloma and acute myeloid leukaemia.

Throughout his 16-year-long research career, Dr Paiva has authored or co-authored more than 200 publications, including more than 30 publications in the most prestigious journal in the haematology sector: Blood. In 2015, Dr Paiva was awarded the Bart Barlogie Young Investigator Award for outstanding research developed in multiple myeloma. In 2022, Dr Paiva was awarded the Brian G.M. Durie Outstanding Achievement Award by the International Myeloma Foundation (IMF) for his contribution to improving the lives of patients with myeloma.